NCT01327612 2021-02-21Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)AmgenPhase 2 Completed12 enrolled 21 charts
NCT01271959 2012-10-05A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry StudyPrecision TherapeuticsTerminated167 enrolled
NCT00314925 2010-02-25Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine FeaturesNeotropixPhase 1 Unknown60 enrolled